ABDIIBRAHIM
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

ABDIIBRAHIM Trademark

Serial Number: 90064573 • Registration: 6662343

ABDIIBRAHIM is a trademark filed by Abdi Ibrahim Ilaç Sanayi ve Tic A.S. on July 21, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Abdi Ibrahim Ilaç Sanayi ve Tic A.S.

Resitpasa Mah.
Sariyer Istanbul 34467 , TR

Entity Type: 09

Trademark Details

Filing Date

July 21, 2020

Registration Date

March 8, 2022

Published for Opposition

December 21, 2021

Goods & Services

Pharmaceutical preparations used for the treatment of bone, joint, vertebral column, intestine, colon, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, and blood diseases and disorders; pharmaceutical preparations for the treatment of autoimmune, immune system, inflammatory, inflammatory bowel, gastrointestinal, genitourinary, musculoskeletal, muscular, dermatological, pulmonary, respiratory, oncological, hepatological, viral, metabolic, endocrine, cardiovascular, cardiopulmonary, sexual dysfunction, ophthalmic, neurological, hormonal, and psychiatric diseases and disorders; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, stomach, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; pharmaceutical preparations to treat or prevent diabetes, coughs, colds, influenza, headaches and allergic reactions; anti-infectives; anti-inflammatories; vaccines; dietetic substances for medical purposes, namely, nutritional, vitamin and mineral supplements and preparations; antiallergic medicines, antidiarrheal medicines, medicines for intestinal disorders, motion sickness medicines, medicines for the treatment of gastrointestinal diseases; medicines for the treatment of cardiovascular and cerebrovascular diseases; prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; medicinal herbal preparations; medicinal preparations for the treatment of diseases of the mouth in the form of sprays; medicinal creams for skin care; propolis for medicinal or therapeutic purposes; medicinal preparations for the treatment of infectious diseases and for use in oncology; medicinal preparations for the treatment of diseases of the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; medicinal syrups for the treatment of cold, nasal and ocular allergic rhinitis, chronic idiopathic urticaria, acute and dry cough, chronic fever, achronic hemodialyses, hyperthyroid, liver and gall bladder disorders, sudden weight loss, non-adequate and non-balanced nutrition, mouth and throat disorders, malaise and fatigue, hyozincemia, respiratory infections, treatment of zinc and iron insufficiency, treatment of irritation of throat and bronchus, and treatment of bipolar manic episode; vitamin and mineral supplements; medicinal syrups containing sodium saccarine, glycerine, banana aroma, strawberry aroma, fruit aroma, orange flavour, sucralose, nicotimanid, fish oil, pelargonium sidoides, xanthan gum, bubble gum aroma, red food dye, peach aroma, yellow food dye, raspberry extract, indigo blue food dye, and caramel for the treatment of cold, nasal and ocular allergic rhinitis, chronic idiopathic urticaria, acute and dry cough, chronic fever, achronic hemodialyses, hyperthyroid, liver and gall bladder disorders, sudden weight loss, non-adequate and non-balanced nutrition, mouth and throat disorders, malaise and fatigue, hyozincemia, respiratory infections, treatment of zinc and iron insufficiency, treatment of irritation of throat and bronchus, and treatment of bipolar manic episode; anti-diabetic pharmaceuticals; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical skin lotions; pharmaceutical preparations for skin care; pharmaceutical preparations for the treatment of erectile dysfunction; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for treating hypertension; pharmaceutical antitussive-cold preparations; pharmaceutical preparations for skin wounds; pharmaceutical preparations for treating hypoglycemia; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for treating asthma; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations for treating allergic rhinitis; pharmaceutical preparations for the treatment of musculo-skeletal disorders; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for treating diseases and disorders of the central nervous system; pharmaceutical preparations for treating allergic rhinitis and asthma; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of immune system related diseases and disorders; all of the foregoing being medicines for human health

Filing History

REGISTERED-PRINCIPAL REGISTER
Mar 8, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 21, 2021 NPUB
PUBLISHED FOR OPPOSITION
Dec 21, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 1, 2021 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Nov 16, 2021 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Nov 12, 2021 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 9, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 9, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 9, 2021 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 9, 2021 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
May 10, 2021 GNFN
FINAL REFUSAL E-MAILED
May 10, 2021 GNFR
FINAL REFUSAL WRITTEN
May 10, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 5, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 4, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 4, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 4, 2020 GNRN
NON-FINAL ACTION E-MAILED
Nov 4, 2020 GNRT
NON-FINAL ACTION WRITTEN
Nov 4, 2020 CNRT
ASSIGNED TO EXAMINER
Nov 4, 2020 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 19, 2020 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 18, 2020 NWOS
NEW APPLICATION ENTERED
Jul 24, 2020 NWAP